2016
DOI: 10.1186/s12864-016-3300-3
|View full text |Cite
|
Sign up to set email alerts
|

Assessing characteristics of RNA amplification methods for single cell RNA sequencing

Abstract: BackgroundRecently, measurement of RNA at single cell resolution has yielded surprising insights. Methods for single-cell RNA sequencing (scRNA-seq) have received considerable attention, but the broad reliability of single cell methods and the factors governing their performance are still poorly known.ResultsHere, we conducted a large-scale control experiment to assess the transfer function of three scRNA-seq methods and factors modulating the function. All three methods detected greater than 70% of the expect… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
36
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
5
3
1

Relationship

2
7

Authors

Journals

citations
Cited by 38 publications
(36 citation statements)
references
References 39 publications
0
36
0
Order By: Relevance
“…There is thus an urgent need to provide comparison and benchmarking information to help guide users make informed choices based on each method's capabilities and limitations, compare newly proposed methods to existing ones, and identify shared weaknesses as targets for experimental improvement. Prior comparisons of scRNA-seq methods [16][17][18][19][20][21] , though useful, have several shortcomings. Many are outdated given the fast-paced field, or are incomplete, inapplicable (e.g., not actually performed with single cells), or insufficiently controlled (e.g., performed using different samples for comparisons); others limit their assessment to basic technical factors, but do not assess the key benchmark of ability to recover meaningful biological information, such as population heterogeneity and structure.…”
mentioning
confidence: 99%
“…There is thus an urgent need to provide comparison and benchmarking information to help guide users make informed choices based on each method's capabilities and limitations, compare newly proposed methods to existing ones, and identify shared weaknesses as targets for experimental improvement. Prior comparisons of scRNA-seq methods [16][17][18][19][20][21] , though useful, have several shortcomings. Many are outdated given the fast-paced field, or are incomplete, inapplicable (e.g., not actually performed with single cells), or insufficiently controlled (e.g., performed using different samples for comparisons); others limit their assessment to basic technical factors, but do not assess the key benchmark of ability to recover meaningful biological information, such as population heterogeneity and structure.…”
mentioning
confidence: 99%
“…The study of cancer has benefited preferential amplification of certain RNA species (i.e., it shows no sequence preference) nor creates significant differences in the ratios of specific aRNAs in the amplified RNA population compared with those of the initial host cell mRNA abundances 3,9 . It should be noted that if there were bias in amplification, then the bias would be linearly amplified rather than exponentially as in PCR amplification. Furthermore, aRNA has been shown to provide an accurate and precise amplification product [9][10][11][12] . aRNA has been used extensively to generate probes for northern and Southern blotting, in tandem with PCR 13,14 and microarrays 4,12,15,16 , and for sequencing of tissue-isolated RNA 7,10,17,18 .…”
Section: Arna-based Insights Into Human Diseasementioning
confidence: 99%
“…1), due to both choice of technology and cost trade-off. We reasoned that when the number of unique molecules drops too low, the signal-noise ratio of the data may be too low to make gene quantification informative 7 , and therefore downstream analyses should be adapted to primarily consider gene detection patterns only.…”
Section: Introductionmentioning
confidence: 99%